Back to Search Start Over

Serial Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: Incremental Value.

Authors :
Felker, Ely R
Felker, Ely R
Wu, Jason
Natarajan, Shyam
Margolis, Daniel J
Raman, Steven S
Huang, Jiaoti
Dorey, Fred
Marks, Leonard S
Felker, Ely R
Felker, Ely R
Wu, Jason
Natarajan, Shyam
Margolis, Daniel J
Raman, Steven S
Huang, Jiaoti
Dorey, Fred
Marks, Leonard S
Source :
The Journal of urology; vol 195, iss 5, 1421-1427; 0022-5347
Publication Year :
2016

Abstract

PurposeWe assessed whether changes in serial multiparametric magnetic resonance imaging can help predict the pathological progression of prostate cancer in men on active surveillance.Materials and methodsA retrospective cohort study was conducted of 49 consecutive men with Gleason 6 prostate cancer who underwent multiparametric magnetic resonance imaging at baseline and again more than 6 months later, each followed by a targeted prostate biopsy, between January 2011 and May 2015. We evaluated whether progression on multiparametric magnetic resonance imaging (an increase in index lesion suspicion score, increase in index lesion volume or decrease in index lesion apparent diffusion coefficient) could predict pathological progression (Gleason 3 + 4 or greater on subsequent biopsy, in systematic or targeted cores). Diagnostic performance of multiparametric magnetic resonance imaging was determined with and without clinical data using a binary logistic regression model.ResultsThe mean interval between baseline and followup multiparametric magnetic resonance imaging was 28.3 months (range 11 to 43). Pathological progression occurred in 19 patients (39%). The sensitivity, specificity, positive predictive value and negative predictive value of multiparametric magnetic resonance imaging was 37%, 90%, 69% and 70%, respectively. Area under the receiver operating characteristic curve was 0.63. A logistic regression model using clinical information (maximum cancer core length greater than 3 mm on baseline biopsy or a prostate specific antigen density greater than 0.15 ng/ml(2) at followup biopsy) had an AUC of 0.87 for predicting pathological progression. The addition of serial multiparametric magnetic resonance imaging data significantly improved the AUC to 0.91 (p=0.044).ConclusionsSerial multiparametric magnetic resonance imaging adds incremental value to prostate specific antigen density and baseline cancer core length for predicting G

Details

Database :
OAIster
Journal :
The Journal of urology; vol 195, iss 5, 1421-1427; 0022-5347
Notes :
application/pdf, The Journal of urology vol 195, iss 5, 1421-1427 0022-5347
Publication Type :
Electronic Resource
Accession number :
edsoai.on1377970070
Document Type :
Electronic Resource